Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    May 2018
  1. HAHN EE, Gould MK
    Lung Cancer Screening and Smoking Cessation: Never Too Early or Too Late.
    J Natl Cancer Inst. 2018 May 16. pii: 4996950. doi: 10.1093.
    PubMed     Text format    


  2. TINDLE HA, Stevenson Duncan M, Greevy RA, Vasan RS, et al
    Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.
    J Natl Cancer Inst. 2018 May 16. pii: 4996947. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. RAFNAR T, Sigurjonsdottir GR, Stacey SN, Halldorsson G, et al
    Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.
    J Natl Cancer Inst. 2018 May 14. pii: 4995938. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  4. NABI H, Provencher L, Diorio C
    RE: Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).
    J Natl Cancer Inst. 2018 Apr 20. pii: 4980806. doi: 10.1093.
    PubMed     Text format    


  5. VERMA V, Simone CB 2nd, Mishra MV
    Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    March 2018
  6. SAMET JM
    Lung Cancer, Smoking, and Obesity: It's Complicated.
    J Natl Cancer Inst. 2018 Mar 6. pii: 4923351. doi: 10.1093.
    PubMed     Text format    


  7. YU D, Zheng W, Johansson M, Lan Q, et al
    Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis.
    J Natl Cancer Inst. 2018 Mar 6. pii: 4923348. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  8. CEDRES S, Felip E, Cruz C, Martinez de Castro A, et al
    Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation.
    J Natl Cancer Inst. 2018 Feb 26. pii: 4911464. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  9. CHENG TD, Darke AK, Redman MW, Zirpoli GR, et al
    Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).
    J Natl Cancer Inst. 2018 Jan 13. pii: 4807490. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. LIN SH, Koong AC
    Breathing New Life Into Hypoxia-Targeted Therapies for Non-Small Cell Lung Cancer.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format    


  11. SALEM A, Asselin MC, Reymen B, Jackson A, et al
    Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  12. FANIDI A, Muller DC, Yuan JM, Stevens VL, et al
    Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3).
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  13. MLECNIK B, Van den Eynde M, Bindea G, Church SE, et al
    Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  14. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  15. HANLEY CJ, Mellone M, Ford K, Thirdborough SM, et al
    Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    December 2017
  16. SONG MA, Benowitz NL, Berman M, Brasky TM, et al
    Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    November 2017
  17. BACH PB, Saltz LB
    Raising the Dose and Raising the Cost: The Case of Pembrolizumab in Lung Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  18. GOLDSTEIN DA, Gordon N, Davidescu M, Leshno M, et al
    A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    October 2017
  19. PAGE BJ, Bowman RV, Yang IA, Fong KM, et al
    RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    J Natl Cancer Inst. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format    


    September 2017
  20. DENIS F, Lethrosne C, Pourel N, Molinier O, et al
    Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  21. CHAIB I, Karachaliou N, Pilotto S, Codony Servat J, et al
    Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    July 2017
  22. ZHOU B, Wang GZ, Wen ZS, Zhou YC, et al
    Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
    J Natl Cancer Inst. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. ROBLES AI, Harris CC
    Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    



  24. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    June 2017
  25. KAWAKAMI M, Mustachio LM, Rodriguez-Canales J, Mino B, et al
    Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  26. LEE CK, Davies L, Wu YL, Mitsudomi T, et al
    Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    March 2017
  27. XU W, Neckers L
    A USE1ful Biomarker and Molecular Target in Lung Cancer?
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format    


  28. XU W, Neckers L
    Editorial: A USE1ful Biomarker and Molecular Target in Lung Cancer?
    J Natl Cancer Inst. 2017;109:1-3.
    PubMed     Text format    


  29. WELLER M, Roth P, Sahm F, Burghardt I, et al
    Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.
    J Natl Cancer Inst. 2017;109:1-4.
    PubMed     Text format     Abstract available


  30. KIM SJ, Hyeong Lee T, Hee Nam S, Kim JH, et al
    Association of Uba6-Specific-E2 (USE1) With Lung Tumorigenesis.
    J Natl Cancer Inst. 2017;109:1-11.
    PubMed     Text format     Abstract available


  31. CELIKTAS M, Tanaka I, Tripathi SC, Fahrmann JF, et al
    Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.
    J Natl Cancer Inst. 2017;109:1-9.
    PubMed     Text format     Abstract available


    January 2017
  32. BROWER V
    Researchers Identify High-Risk Subtype of Stage I Lung Cancer.
    J Natl Cancer Inst. 2017;109:3-4.
    PubMed     Text format    


  33. PELOSOF L, Ahn C, Gao A, Horn L, et al
    Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  34. SHUKLA S, Evans JR, Malik R, Feng FY, et al
    Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    December 2016
  35. ZUBER V, Marconett CN, Shi J, Hua X, et al
    Pleiotropic Analysis of Lung Cancer and Blood Triglycerides.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    October 2016
  36. POLLEY E, Kunkel M, Evans D, Silvers T, et al
    Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  37. GAZDAR AF, Minna JD
    Developing New, Rational Therapies for Recalcitrant Small Cell Lung Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    July 2016
  38. HO GY, Zheng SL, Cushman M, Perez-Soler R, et al
    Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  39. ROCHMAN S
    High Glycemic Index Associated With Increased Lung Cancer Risk.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  40. HEALY MA, Yin H, Reddy RM, Wong SL, et al
    Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    June 2016
  41. FILLON M
    Continuing To Smoke After Breast Cancer Diagnosis Lowers Survival Rate.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    April 2016
  42. WESTBROOK JA, Cairns DA, Peng J, Speirs V, et al
    CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    March 2016
  43. SCHILD SE, Ashman JB, Keole SR, Daniels TB, et al
    RE: Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  44. KOSHY M, Malik R, Mahmood U, Husain Z, et al
    Response.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  45. GOBBO J, Marcion G, Cordonnier M, Dias AM, et al
    Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  46. DELUDE C
    Naming and Staging Lung Cancers.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    February 2016
  47. TENG CJ, Hu YW, Chen SC, Yeh CM, et al
    Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  48. ZINDLER JD, Thomas CR Jr, Hahn SM, Hoffmann AL, et al
    Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    January 2016
  49. JENKS S
    Is Lung Cancer Incidence Increasing in Never-Smokers?
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  50. SCHMIDT C
    Metastatic Cells Colonize Implantable Scaffold in Mice.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  51. CORTEZ MA, Ivan C, Valdecanas D, Wang X, et al
    PDL1 Regulation by p53 via miR-34.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  52. WONG V, Pavlick D, Brennan T, Yelensky R, et al
    Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  53. ALFANO CM, Bluethmann SM, Tesauro G, Perna F, et al
    NCI Funding Trends and Priorities in Physical Activity and Energy Balance Research Among Cancer Survivors.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    December 2015
  54. ROCHMAN S
    Genetic Test Finds Radiation Sensitivity Differs Between Primary Tumor and Metastatic Sites.
    J Natl Cancer Inst. 2015;107:djv397.
    PubMed     Text format    


  55. SAMPSON JN, Wheeler WA, Yeager M, Panagiotou O, et al
    Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.
    J Natl Cancer Inst. 2015;107:djv279.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: